
Overview
Norsa Pharma is a Polish manufacturer that offers a wide range of specialized dietary supplements tailored to various health needs. Their product lineup includes items such as Omegasense Gold, Creatine Nucleo, and Vitamin D3+K2, among others. The company focuses on nutritional preparations to support health and well-being.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 90 days late).
- 202519/05/2026
- 202409/04/2025
- 202313/07/2024
- 202213/07/2023
- 202113/10/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Electrolytes
- Dietary nucleotides
- Immune support supplement
- Thyroid supplement
- Digestive preparations
- Omega-3 supplement
- Hair and skin supplement
Websites
The sites are available in: Polish and English.
- cystisorb.plCystisorb | żywność specjalnego przeznaczenia medycznego dla osób chorych na mukowiscydozęWordPress 5.7DDiviApache
- norsapharma.comSklep Norsa Pharma – suplementy diety i specjalistyczne preparaty żywieniowe, polski producentWooCommerceWordPress 7.1ElementorGoogle Tag ManagerRRank MathApache
- thyroset.plThyroset – zestaw witamin i minerałów przy niedoczynności tarczycy i HashimotoGoogle Tag ManagerMeta PixelApache
Trademarks
The company holds 23 active trademarks registered with the Polish Patent Office. 2 applications are pending. 6 marks have expired or were not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| iONA+ (word) | Apr 27, 2036 | |
| Duofibrin (word) | Feb 12, 2036 | |
| NORDIGAST (word) | Dec 3, 2035 | |
| CreatineNucleo (word) | Aug 13, 2035 | |
| Omegasense (word) | Jun 26, 2035 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 12 | $324.15 | 16% | |
Mateusz Łukasz Data age 43 | 33 | $891.41 | 44% |
Marta Kowal age 43 | 17 | $459.21 | 22.6667% |
Jarosław Mirosław Walkowiak age 59 | 8 | $216.10 | 10.6667% |
Arkadiusz Michalski | 5 | $135.06 | 6.6666% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-02-13.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $708,549.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-07-01 | Comprehensive treatment options for nutritional deficiencies in cystic fibrosis: bioavailability, efficacy, cost reduction. | $449.8K$449,843 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ekamedica sp. z o.o. + limited partnership | $18,889,143.89 | ekamedica.pl | ||
| ALG Pharma sp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Nutropharma sp. z o.o. | $13,240,122.91 | nutropharma.pl | ||
| Aura Herbals sp. z o.o. | $11,101,586.81 | auraherbals.pl | ||
| Best Lab sp. z o.o. | $11,045,123.42 | bestlab.com.pl | ||
| Panawit sp. z o.o. | $10,791,432.08 | panawit.pl | ||
| Intenson S.A. | $10,803,093.83 | intenson.pl | ||
| Polamedica sp. z o.o. | $7,562,655.71 | polamedica.com.pl | ||
| BIO Herbs sp. z o.o. | $4,440,592.90 | bio-herbs.eu | ||
| Pharma Nord sp. z o.o. | $1,701,654.59 | pharmanord.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-11-13 | Address change (Ul. Prof. Michała Życzkowskiego 14, 31-864, Kraków → Ul. Mogilska 65, 31-545, Kraków) | |
| 2025-06-20 | Switch to PKD 2025 (6 PKD 2007 codes → 3 PKD 2025 codes) | |
| 2020-02-20 | Share capital increase (6,900.00 PLN → 7,500.00 PLN) | |
| 2019-11-27 | Share capital increase (6,300.00 PLN → 6,900.00 PLN) | |
| 2018-06-11 | Address change (Ul. Czerwone Maki 84, 32-392, Kraków → Ul. Prof. Michała Życzkowskiego 14, 31-864, Kraków) |
FAQ
Last updated: 2026-11-13
